Baxter to buy Swedish firm Gambro

  • December 4, 2012

Drug and medical device maker Baxter International says it will buy the privately held Swedish company Gambro in a deal valued at about $2.76 billion to broaden its dialysis product portfolio.

The Deerfield, Ill., company says Gambro makes dialysis products for patients with acute or chronic kidney disease. It had sales of about $1.6 billion last year.

Baxter International Inc. says dialysis treatment rates are rising more than 5 percent annually, partly because of rising rates of diabetes and high blood pressure.

Baxter will pay for the deal with a combination of debt and cash generated from overseas operations. It expects the acquisition to close in the first half of next year. The deal is worth about $4 billion, counting debt.


blog comments powered by Disqus

Dakota city that grew on fracking reaching out for more retail

Super Bowl of shopping unfolds

Coat giveaway better than any Black Friday sale

Orders for U.S. durable goods rise strong 3 percent in October

Applications for U.S. unemployment benefits fall to 260,000

Deere’s profit tops forecasts even as its sales fall sharply

Consumer spending up a weak 0.1 percent in October

Work begins on outdoor venue at The Meadows

Consumer confidence falls hard in November

Home prices jump in September by most in more than a year